Eli Lilly appoints Luca Visini as MD of India operations

Published On 2018-02-15 04:30 GMT   |   Update On 2018-02-15 04:30 GMT

New Delhi: US pharma major Eli Lilly and Company said it has appointed Luca Visini as managing director of its Indian subsidiary with effect from February 1, 2018.


Visini replaces Edgard Olaizola, who headed Lilly India operations from September 2013 to January 2018, and will now be moving internally to a new role.


Visini joined Lilly in 2004 and held several strategic leadership roles in various functional departments out of Lilly headquarters in Indianapolis, the USA, and Europe.


From 2011 to 2014, he was the country manager for Lilly Romania.


Commenting on the appointment, Visini said: "I am taking the lead of Lilly India in a year that marks Lilly's 25-year presence in India, and that will witness the launch of several innovative medications which will help answer unmet needs."


Lilly has a strong heritage and experience in the research, development, and management of chronic diseases such as cancer and diabetes and the company is determined to engage with all stakeholders in the healthcare field in India to help people live longer healthier and more active lives, he added.


In 1993, Eli Lilly and Company established its wholly- owned subsidiary Eli Lilly and Company (India) Pvt Ltd, headquartered in Gurgaon.


Since then, Lilly India has expanded its operations considerably in the country.

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News